Financhill
Back

Vaxcyte Stock Predictions

Vaxcyte Stock Forecast

  • Over the next 52 weeks, Vaxcyte has on average historically risen by 30.5% based on the past 4 years of stock performance.
  • Vaxcyte has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Vaxcyte Stock Undervalued?
    The current Vaxcyte [PCVX] share price is $31.85. The Score for PCVX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • PCVX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Vaxcyte Stock Go Up Next Year?

  • Over the next 52 weeks, Vaxcyte has on average historically risen by 30.5% based on the past 4 years of stock performance.

Vaxcyte Stock Rating

Sell
40
Vaxcyte (PCVX) is a Sell

Is Vaxcyte overpriced?

  • Vaxcyte has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Vaxcyte Stock Price History

Is PCVX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PCVX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vaxcyte.com

52-Week Data

52-Week High:
121.06
52-Week Low:
27.66

Prediction Charts

Market Cap:
4.1B
Price in USD:
31.85
Volume:
1.5M
Beta:
1.29

Technical Analysis

SMA50:
45.04
SMA100:
64.57
SMA200:
81.21
52-Wk Change:
-57.79%

Stock Predictions

  • Is Vaxcyte stock public?
    Yes, Vaxcyte is a publicly traded company.
  • What is the Vaxcyte stock quote today?
    The Vaxcyte stock price is 31.85 USD today.
  • How to buy Vaxcyte stock online?
    You can buy Vaxcyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-29 32.72 34.77 34.90 32.27
Apr-30 34.25 35.84 36.25 34.07
May-1 35.72 35.24 36.26 31.27
May-2 35.75 35.39 36.71 34.90
May-5 35.48 34.28 35.56 34.17
May-6 34.19 29.24 34.75 29.15
May-7 29.81 29.00 30.04 28.09
May-8 30.31 31.45 33.75 29.93
May-9 31.29 31.16 33.47 31.07
May-12 32.49 31.59 32.99 31.42
May-13 31.69 30.05 32.02 29.99
May-14 30.07 29.42 30.38 28.64
May-15 29.56 30.90 31.15 29.00
May-16 30.97 31.85 32.53 30.65

Vaxcyte Earnings

Vaxcyte Earnings Report: Per Share Vaxcyte Earnings Q1 Q2 Q3 and Q4 last year and next year.

Vaxcyte Forecast Revenue Growth

Vaxcyte Stock Analysis: Historical quarterly revenues per share for Vaxcyte and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.14 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.52 per share.

* Vaxcyte stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.